Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110a. (2023)
Attributed to:
Cancer drug discovery targeting the interaction of RAS oncogenic proteins with phosphoinositide 3-kinase
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-023-28756-0
PubMed Identifier: 36732563
Publication URI: http://europepmc.org/abstract/MED/36732563
Type: Journal Article/Review
Volume: 13
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322